BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirzaei H, Ghorbani S, Khanizadeh S, Namdari H, Faghihloo E, Akbari A. Histone deacetylases in virus-associated cancers. Rev Med Virol 2020;30:e2085. [PMID: 31743548 DOI: 10.1002/rmv.2085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Peng Q, Tan S, Xia L, Wu N, Oyang L, Tang Y, Su M, Luo X, Wang Y, Sheng X, Zhou Y, Liao Q. Phase separation in Cancer: From the Impacts and Mechanisms to Treatment potentials. Int J Biol Sci 2022;18:5103-22. [PMID: 35982902 DOI: 10.7150/ijbs.75410] [Reference Citation Analysis]
2 Patra SK, Szyf M. Epigenetic perspectives of COVID-19: Virus infection to disease progression and therapeutic control. Biochim Biophys Acta Mol Basis Dis 2022;1868:166527. [PMID: 36002132 DOI: 10.1016/j.bbadis.2022.166527] [Reference Citation Analysis]
3 Hai R, Yang D, Zheng F, Wang W, Han X, Bode AM, Luo X. The emerging roles of HDACs and their therapeutic implications in cancer. Eur J Pharmacol 2022;931:175216. [PMID: 35988787 DOI: 10.1016/j.ejphar.2022.175216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ghorbani S, Letafati A, Khatami A, farzi R, Shabani S, Moradi P, Tambrchi V, Saadati H, Papizadeh S, rad MV, Tabatabaei R, Bahadory S, Tavakoli A, Bokharaei-salim F, Monavari SH, Fatemipour M, Hoseini M, Kiani SJ. Association between human herpesvirus-6 and primary brain tumors: a systematic review and meta-analysis. Future Virology. [DOI: 10.2217/fvl-2021-0096] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lopes JR, Prokopczyk IM, Gerlack M, Man Chin C, Santos JLD. Design and Synthesis of Hybrid Compounds as Epigenetic Modifiers. Pharmaceuticals (Basel) 2021;14:1308. [PMID: 34959707 DOI: 10.3390/ph14121308] [Reference Citation Analysis]
6 Hai R, He L, Shu G, Yin G. Characterization of Histone Deacetylase Mechanisms in Cancer Development. Front Oncol 2021;11:700947. [PMID: 34395273 DOI: 10.3389/fonc.2021.700947] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Nagaraju GP, Kasa P, Dariya B, Surepalli N, Peela S, Ahmad S. Epigenetics and therapeutic targets in gastrointestinal malignancies. Drug Discov Today 2021:S1359-6446(21)00202-6. [PMID: 33895313 DOI: 10.1016/j.drudis.2021.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wei Z, Liu X, Cheng C, Yu W, Yi P. Metabolism of Amino Acids in Cancer. Front Cell Dev Biol 2020;8:603837. [PMID: 33511116 DOI: 10.3389/fcell.2020.603837] [Cited by in Crossref: 6] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
9 Khatami A, Pormohammad A, Farzi R, Saadati H, Mehrabi M, Kiani SJ, Ghorbani S. Bovine Leukemia virus (BLV) and risk of breast cancer: a systematic review and meta-analysis of case-control studies. Infect Agent Cancer 2020;15:48. [PMID: 32704306 DOI: 10.1186/s13027-020-00314-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zuo Y, Xu H, Chen Z, Xiong F, Zhang B, Chen K, Jiang H, Luo C, Zhang H. 17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells. Oncol Rep 2020;43:1928-44. [PMID: 32236631 DOI: 10.3892/or.2020.7563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]